Beauty Health Co (SKIN) Financial Ratio Screen

NASDAQ Consumer Defensive United States USD 103M
RATIOS FAIL*
Automated financial screen · activity assessed separately
Beauty Health Co (SKIN) is potentially non-compliant in the automated ratio model. The company's debt ratio of 75.8% exceeds the 30% MSCI new-inclusion threshold relative to total assets. Beauty Health Co operates in the Consumer Defensive sector.

Track SKIN screening changes

Get an email when this stock's published screening status or underlying ratios change.

MSCI new-inclusion financial-ratio snapshot

SKIN financial screening at a glance

RATIOS FAIL*Financial ratios shown separately from business review — not a fatwa
Debt ratio
75.8%
Fail vs 30%
Cash ratio
46.6%
Fail vs 30%
Receivables + cash
51.2%
Fail vs 30%
Impermissible income
3.0%
Pass vs 5%

Calculation date: 2026-08-31. Financial period used: December 2025. The ratios are automated proxies inspired by published methodologies; they are not official index determinations.

Independent method comparison

What the available screens say

How MSCI, FTSE and S&P-style screens differ
Request this stock review
MSCI-styleFinancial criteria not metAt least one available ratio exceeds its threshold
FTSE/Yasaar-styleFinancial criteria not metAt least one available ratio exceeds its threshold
S&P-style provisionalNot yet availableRequired denominator or financial data is incomplete
Business activityAssessment pendingFinancial results do not determine business permissibility
Complete screening result: not yet completeA complete result requires both supported financial criteria and adequate activity evidence. This site does not issue a fatwa or official index decision.
Financial periodDecember 2025Calculation date2026-08-31S&P-style historynot availableLast activity reviewnot yet reviewed

The request button opens your email application with a pre-filled message. HalalStockGuide receives no address or request unless you choose to send it.

Business activity evidence

Activity assessment in progress

The supplied classification (Household & Personal Products) is only a starting point. Revenue evidence is being assessed before any complete screening conclusion.

Revenue segments: Not yet checked against an SEC annual filing.

Profile description reviewed: The Beauty Health Company, a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.

Sources to verify: Secondary company profile and classification · Issuer website · SEC issuer filings

A sector label or company description can flag a risk but cannot establish a compliant-revenue percentage. Only sourced segment disclosures may support that calculation.

Published-ratio reproductions (not certifications)

The table shows implemented MSCI and FTSE/Yasaar-style asset-based models plus a provisional S&P-style leverage reconstruction where a complete 36-month denominator exists. These are independent calculations, not official index results or Shariah determinations. See formulas, sources and limitations.

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
MSCI 75.8%
/ 30%
46.6%
/ 30%
51.2%
/ 30%
2.98%
/ 5%
RATIOS FAIL*
FTSE 75.8%
/ 33%
46.6%
/ 33%
51.2%
/ 50%
2.98%
/ 5%
RATIOS FAIL*

Financial Highlights

EPS
$-0.16
P/B Ratio
1.7
EV/EBITDA
55.2
EV: $251M
Revenue
$301M
Growth: -1.4%
Beta
1.2
High volatility
Current Ratio
1.7

Profitability

Gross Margin 65.3%
Operating Margin 0.2%
Net Margin -3.2%
Return on Equity (ROE) -16.9%
Return on Assets (ROA) -2.2%

Cash Flow & Balance Sheet

Operating Cash Flow$37M
Free Cash Flow$32M
Total Debt$379M
Debt-to-Equity620.3
Current Ratio1.7
Total Assets$500M

Price & Trading

Last Close$0.90
50-Day MA$1.20
200-Day MA$1.59
Avg Volume627K
Beta1.2
52-Week Range
$0.78
$2.69

Financial data provenance and verification

The displayed fields were imported from yfinance on 2026-03-29 for the financial period December 2025. This is a secondary data feed and can differ from amended or newly filed statements.

Verification rule: check debt, cash, receivables, revenue and interest income against the latest primary filing before relying on an automated ratio.

About Beauty Health Co (SKIN)

CEO
Mr. Pedro Malha
Employees
613
Sector
Consumer Defensive
Industry
Household & Personal Products
Country
United States
Exchange
NASDAQ
Market Cap (listing currency)
USD 103M
Currency
USD

The Beauty Health Company, a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.

Popular halal stock checks

Explore other frequently viewed automated stock screens and compare the available financial ratios.

Frequently Asked Questions

Is Beauty Health Co (SKIN) halal to invest in?

The current automated result is Financial criteria not met or an activity exclusion was detected. It uses available public financial fields and simplified methodology proxies. It is not a fatwa or an official determination by AAOIFI, DJIM, MSCI, S&P, or FTSE.

What is Beauty Health Co's debt ratio?

Beauty Health Co's debt ratio is 75.8% in the MSCI new-inclusion reproduction: total debt divided by total assets, against a 30% threshold. See the methodology page for the official source and limitations.

What are Beauty Health Co's key financial metrics?

Beauty Health Co has a market capitalization of USD 103M in its listing currency, and revenue of $301M. The company maintains a gross margin of 65.3% and a net margin of -3.2%. Return on equity stands at -16.9%.

How often is the screening data updated?

Calculation date: 2026-08-31. Financial period: December 2025. These dates are shown separately because regenerating this page does not refresh the underlying data.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.